---
title: "仅肿瘤样本的RNAseq也可以call 突变了"
date: 2026-02-06T00:04:00Z
draft: ["false"]
tags: [
  "fetched",
  "生信菜鸟团"
]
categories: ["Acdemic"]
---
仅肿瘤样本的RNAseq也可以call 突变了 by 生信菜鸟团
------
<div><table><thead><tr><th data-colwidth="90"><section><span leaf=""><span textstyle="">Title</span></span></section></th><th><section><span leaf=""><span textstyle="">Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification</span></span></section></th></tr></thead><tbody><tr><td data-colwidth="90"><section><span leaf=""><span textstyle="">Online</span></span></section></td><td><section><span leaf=""><span textstyle="">https://www.nature.com/articles/s41467-022-29336-y</span></span></section></td></tr></tbody></table><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8VNCloxNWOglvIcCA15knOjV0cj8Ph5ic1oIqUbib9gyv2PTPz03y0AxLa9W9jflicCeciasH6fZb96xez2CagxF74FmbTic3b2K1DE/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.3675925925925926" data-type="png" data-w="1080" data-imgfileid="100055738" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8VNCloxNWOglvIcCA15knOjV0cj8Ph5ic1oIqUbib9gyv2PTPz03y0AxLa9W9jflicCeciasH6fZb96xez2CagxF74FmbTic3b2K1DE/640?wx_fmt=png&amp;from=appmsg"></section><h3><span leaf="">研究背景</span></h3><p><span leaf="">既往儿童急性髓系白血病（AML）的基因组研究主要基于西方人群，但不同种族背景可能影响疾病分子特征。本研究旨在系统描绘中国儿童AML的基因组图谱，并与西方队列比较，探索种族差异对临床风险分层的影响。</span></p><h3><span leaf="">研究方法</span></h3><p><span leaf="">患者和样本：292例2001–2018年上海儿童医学中心收治的中国儿童AML患者</span></p><p><span leaf="">测序和数据处理：RNAseq双端测序，读长150bp。然后基于转录组数据进行call变异，主要用到 Mutect2 和Rnaindel工具。</span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100055740" data-ratio="0.4703703703703704" data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8VY7wUaAPdicQAmiccvFqMKYPnjcVyGHE5LmskUu1f5UUOOCnQn97INA6W594z23Ziap2ryxd9nqx8BnDXVM9rpUicBVIj9EYvEfOs/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8VY7wUaAPdicQAmiccvFqMKYPnjcVyGHE5LmskUu1f5UUOOCnQn97INA6W594z23Ziap2ryxd9nqx8BnDXVM9rpUicBVIj9EYvEfOs/640?wx_fmt=png&amp;from=appmsg"></section><p><span leaf="">突变过滤：在得到突变列表之后进行过滤和分级：</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Go1sLc9TF8W6yQK73CKNraulN3XiaM2ibpmjpIqGLpD9wTbECdMosmE8vV4niculbGvHhTVSYB24BD3eq99KsNhYSnqpluHKctQ7XS8wxVDsNw/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.3891891891891892" data-type="png" data-w="925" data-imgfileid="100055737" data-aistatus="1" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Go1sLc9TF8W6yQK73CKNraulN3XiaM2ibpmjpIqGLpD9wTbECdMosmE8vV4niculbGvHhTVSYB24BD3eq99KsNhYSnqpluHKctQ7XS8wxVDsNw/640?wx_fmt=png&amp;from=appmsg"></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Go1sLc9TF8XwTia9ZvEwOBiaW4XF0JicAafic36hxAibEuAicHIobGsIJBER6FhbiczDAibAfYMFCyKg4xynk0NcSTCshaPiaDaIAx0ia7wTzEiaennoLo/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.3764961915125136" data-type="png" data-w="919" data-imgfileid="100055739" data-aistatus="1" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Go1sLc9TF8XwTia9ZvEwOBiaW4XF0JicAafic36hxAibEuAicHIobGsIJBER6FhbiczDAibAfYMFCyKg4xynk0NcSTCshaPiaDaIAx0ia7wTzEiaennoLo/640?wx_fmt=png&amp;from=appmsg"></section><h3><span leaf="">研究结果</span></h3><p><span leaf="">中国儿童 AML 中的基因融合：在292例中发现3例携带XPO1融合，全部属于M7亚型（急性巨核细胞白血病），该融合可能定义了M7亚型中一个新的分子亚型。XPO1抑制剂已有上市药物，可能为靶点治疗提供机会。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8XeMic1AcQ7g3noqqD6P3RCq0aZv2ICmeAAOqAa41T4fECCOxU36ucHL3kEMpgn8cpr1PI0oLicfjC8M91y2XltZeyBqQhib3d8TY/640?wx_fmt=png&amp;from=appmsg" data-ratio="1.5087890625" data-type="png" data-w="1024" data-imgfileid="100055741" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8XeMic1AcQ7g3noqqD6P3RCq0aZv2ICmeAAOqAa41T4fECCOxU36ucHL3kEMpgn8cpr1PI0oLicfjC8M91y2XltZeyBqQhib3d8TY/640?wx_fmt=png&amp;from=appmsg"></section><p><span leaf="">中西方人群突变谱差异：研究团队将中国队列（SCMC, n=292）与西方TARGET AML队列（n=498）进行系统比较，发现显著差异：以下基因在中国人群突变频率更高：</span></p><table><thead><tr><th><section><span leaf="">基因/区域</span></section></th><th><section><span leaf="">中国队列</span></section></th><th><section><span leaf="">西方队列</span></section></th><th><section><span leaf="">P值</span></section></th></tr></thead><tbody><tr><td><strong><span leaf="">KIT exon 17</span></strong></td><td><section><span leaf="">13.9%</span></section></td><td><section><span leaf="">7.9%</span></section></td><td><section><span leaf="">0.020</span></section></td></tr><tr><td><strong><span leaf="">CSF3R胞质域</span></strong></td><td><section><span leaf="">4.5%</span></section></td><td><section><span leaf="">0.6%</span></section></td><td><section><span leaf="">&lt;0.001</span></section></td></tr><tr><td><strong><span leaf="">ASXL2</span></strong></td><td><section><span leaf="">7.3%</span></section></td><td><section><span leaf="">3.4%</span></section></td><td><section><span leaf="">0.025</span></section></td></tr><tr><td><strong><span leaf="">JAK2</span></strong></td><td><section><span leaf="">5.2%</span></section></td><td><section><span leaf="">0.0%</span></section></td><td><section><span leaf="">&lt;0.001</span></section></td></tr></tbody></table><p><span leaf="">以下基因在中国人群突变频率更低：</span></p><table><thead><tr><th><section><span leaf="">基因</span></section></th><th><section><span leaf="">中国队列</span></section></th><th><section><span leaf="">西方队列</span></section></th><th><section><span leaf="">P值</span></section></th></tr></thead><tbody><tr><td><strong><span leaf="">NRAS</span></strong></td><td><section><span leaf="">17.7%</span></section></td><td><section><span leaf="">31.5%</span></section></td><td><section><span leaf="">&lt;0.001</span></section></td></tr><tr><td><strong><span leaf="">FLT3-ITD</span></strong></td><td><section><span leaf="">7.3%</span></section></td><td><section><span leaf="">16.1%</span></section></td><td><section><span leaf="">0.002</span></section></td></tr><tr><td><strong><span leaf="">FLT3总体</span></strong></td><td><section><span leaf="">19.1%</span></section></td><td><section><span leaf="">31.7%</span></section></td><td><section><span leaf="">0.003</span></section></td></tr><tr><td><strong><span leaf="">WT1</span></strong></td><td><section><span leaf="">2.4%</span></section></td><td><section><span leaf="">13.7%</span></section></td><td><section><span leaf="">&lt;0.001</span></section></td></tr><tr><td><strong><span leaf="">NPM1</span></strong></td><td><section><span leaf="">2.1%</span></section></td><td><section><span leaf="">8.6%</span></section></td><td><section><span leaf="">&lt;0.001</span></section></td></tr><tr><td><strong><span leaf="">TET2</span></strong></td><td><section><span leaf="">1.4%</span></section></td><td><section><span leaf="">4.4%</span></section></td><td><section><span leaf="">0.036</span></section></td></tr></tbody></table><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8VLxQRQadfxZicHtqChm37nqYrYh0MUl0bfFcLvriaU6xPVbQ0zEtcCDhtmgiakFG1QzMILjulwfZ4mibT9UgKhf2TVIuT9VicmExr8/640?wx_fmt=png&amp;from=appmsg" data-ratio="1.4902534113060428" data-type="png" data-w="1026" data-imgfileid="100055745" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8VLxQRQadfxZicHtqChm37nqYrYh0MUl0bfFcLvriaU6xPVbQ0zEtcCDhtmgiakFG1QzMILjulwfZ4mibT9UgKhf2TVIuT9VicmExr8/640?wx_fmt=png&amp;from=appmsg"></section><p><span leaf="">突变共现模式差异：将93个驱动基因进行通路分析，发现主要分为6条通路：转录调控、表观遗传、细胞周期、Cohesin、RAS信号和其他信号通路。突变共现分析发现150对显著共现或互斥的突变组合。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8Vyk0zpCa0naJPnNvgdsdQeLs4fuRLoCcHdibwIAsRKh9OrdglibWoSfDDNbUHnXoYQq0nJF8qZTuEnn9rq6cMEx2dK5bfKLsqic4/640?wx_fmt=png&amp;from=appmsg" data-ratio="1.448536355051936" data-type="png" data-w="1059" data-imgfileid="100055744" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8Vyk0zpCa0naJPnNvgdsdQeLs4fuRLoCcHdibwIAsRKh9OrdglibWoSfDDNbUHnXoYQq0nJF8qZTuEnn9rq6cMEx2dK5bfKLsqic4/640?wx_fmt=png&amp;from=appmsg"></section><p><span leaf="">预后风险分析：CBFB-MYH11融合预后良好，而NUP98-KDM5A/NSD1、FUS-ERG、CBFA2T3-GLIS2则与不良预后相关。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8UZv49icXn45cJ0FtE5docYJw4jrvfX6GoVYsEdPzWyrjeMX40pGIbvoKfcAS22cfo29GgmoZqwErZw8rXE9PpIseYicxVia3E6gI/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.4083333333333333" data-type="png" data-w="1080" data-imgfileid="100055743" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8UZv49icXn45cJ0FtE5docYJw4jrvfX6GoVYsEdPzWyrjeMX40pGIbvoKfcAS22cfo29GgmoZqwErZw8rXE9PpIseYicxVia3E6gI/640?wx_fmt=png&amp;from=appmsg"></section><p><span leaf="">风险分层模型：基于上述发现，研究团队提出了针对中国儿童AML的修订风险分层模型——SCMC-pAML模型，模型主要改进的要点有：</span></p><p><span leaf="">保留：FUS-ERG、CBFA2T3-GLIS2、NUP98-KDM5A、NUP98-NSD1为高危</span></p><p><span leaf="">调整：KMT2A重排调整为中危（而非高危）</span></p><p><span leaf="">细化：RUNX1-RUNX1T1融合患者根据CR1状态和CSF3R/KIT-E17突变进一步分层</span></p><p><span leaf="">新增：未达到CR1的患者直接归为高危</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8WTLstaCT3MqgWasNJclLPGzMic0DfcAGQ2hEt1HkUfPKTFiaxic89yBNwd5TZwEK8AdZ5TCIbroDicTpoIPwdJAKc07BAKnmpR3kY/640?wx_fmt=png&amp;from=appmsg" data-ratio="2.2890625" data-type="png" data-w="640" data-imgfileid="100055742" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Go1sLc9TF8WTLstaCT3MqgWasNJclLPGzMic0DfcAGQ2hEt1HkUfPKTFiaxic89yBNwd5TZwEK8AdZ5TCIbroDicTpoIPwdJAKc07BAKnmpR3kY/640?wx_fmt=png&amp;from=appmsg"></section><h3><span leaf="">总结</span></h3><p><span leaf="">该研究开发了针对肿瘤-only RNA-seq数据的突变检测流程，发现XPO1-TNRC18融合事件，并可能作为M7亚型的新分子标志物，构建了SCMC-pAML风险分层模型，更适合中国儿童AML患者。总的来说，该研究是中国儿童AML基因组学领域的里程碑工作，不仅填补了人群数据的空白，更重要的是建立了更适合中国患者的临床风险分层体系，体现了精准医学中"人群特异性"的核心原则。</span></p><section><span leaf=""><br></span></section><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/xsP85mzHQV2MxfzdM3dROg",target="_blank" rel="noopener noreferrer">原文链接</a>
